Ticker

No recent analyst price targets found for CRVL.

Latest News for CRVL

Head to Head Analysis: CorVel (NASDAQ:CRVL) versus Wellgistics Health (NASDAQ:MEDS)

Wellgistics Health (NASDAQ: MEDS - Get Free Report) and CorVel (NASDAQ: CRVL - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability. Earnings and Valuation This table compares Wellgistics Health and

Defense World • Sep 3, 2026
Assenagon Asset Management S.A. Sells 95,906 Shares of CorVel Corp. $CRVL

Assenagon Asset Management S.A. reduced its stake in CorVel Corp. (NASDAQ: CRVL) by 48.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 101,952 shares of the business services provider's stock after selling 95,906 shares during the period.

Defense World • Aug 12, 2026
CorVel Q1 Earnings Call Highlights

CorVel NASDAQ: CRVL reported June-quarter revenue of $260 million, up 11% from $235 million in the June 2025 quarter, while earnings per share rose 22% to $0.63 from $0.52 a year earlier.

MarketBeat • Aug 5, 2026
CorVel Announces Revenues and Earnings

FORT WORTH, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2026. Revenues for the quarter were $260 million, an increase from $235 million in the June quarter of 2025. Earnings per share for the quarter were $0.63, compared to $0.52 in the same quarter of the prior year.

GlobeNewsWire • Aug 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CRVL.

No House trades found for CRVL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top